Eagle Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Eagle Pharmaceuticals Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Eagle Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Eagle Pharmaceuticals Inc.

Back to companies

Eagle Pharmaceuticals Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Eagle Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US20230390295A1 Application Pemetrexed formulations A61K31/519; A61K47/02; A61K47/10; A61K9/0019 December 07, 2023
US11819550B2 Grant Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP) A61K38/00; A61K39/3955; A61K47/06; A61K47/20; A61K47/22; A61K47/24; A61K9/0019; A61K9/19; C07K16/22; C07K16/241; C07K16/2839; C07K16/2863; C07K16/2887; C07K16/32 November 21, 2023
AU2023251546A1 Application Liquid protein formulations containing ionic liquids A61G3/00; A61K2039/505; A61K38/00; A61K39/395; A61K39/3955; A61K47/06; A61K47/12; A61K47/20; A61K47/22; A61K47/24; A61K9/0019; A61K9/08; A61K9/19; A61P25/00; A61P29/00; A61P31/00; A61P35/00; A61P37/06; A61P43/00; A61P7/00; C07K1/14; C07K16/22; C07K16/241; C07K16/2839; C07K16/2863; C07K16/2887; C07K16/32; Y02P20/54 November 16, 2023
EP4272763A2 Application Flüssige proteinformulierungen mit organophosphaten A61G3/00; A61K2039/505; A61K38/00; A61K39/395; A61K39/3955; A61K47/06; A61K47/12; A61K47/20; A61K47/22; A61K47/24; A61K9/0019; A61K9/08; A61K9/19; A61P25/00; A61P29/00; A61P31/00; A61P35/00; A61P37/06; A61P43/00; A61P7/00; C07K1/14; C07K16/22; C07K16/241; C07K16/2839; C07K16/2863; C07K16/2887; C07K16/32; Y02P20/54 November 08, 2023
SI3043772T1 Grant Liquid protein formulations containing organophosphates A61G3/00; A61K2039/505; A61K38/00; A61K39/395; A61K39/3955; A61K47/06; A61K47/12; A61K47/20; A61K47/22; A61K47/24; A61K9/0019; A61K9/08; A61K9/19; A61P25/00; A61P29/00; A61P31/00; A61P35/00; A61P37/06; A61P43/00; A61P7/00; C07K1/14; C07K16/22; C07K16/241; C07K16/2839; C07K16/2863; C07K16/2887; C07K16/32; Y02P20/54 October 30, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer